Poll: Do You Offer Annual Mammography Screening to Women 40 Years and Older?

Wendie Berg, MD, PhD, discusses new breast density guidelines

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

Image credit: © Gorodenkoff - stock.adobe.com

Reducing geriatric breast cancer screening through cessation messaging

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.

Alzheimer disease risk reduced by hormone therapy for breast cancer treatment

In a recent study, older women receiving messages about breast cancer screening cessation were more likely to support stopping screening than those who did not receive a message.

Integrating HCV screening with breast cancer programs enhances care

A recent study found that hormone therapy use in breast cancer patients aged 65 years and older is associated with a reduced risk of Alzheimer's and related dementias.

Abigail Brooks, MA

Neighborhood deprivation linked to higher breast cancer mortality in White women

A recent study from France demonstrates that incorporating hepatitis C virus screening into breast cancer programs significantly improves patient engagement and access to effective antiviral treatments among older women.

International group publishes first clinical guidance on polygenic risk scores for breast cancer

A recent study reveals that non-Hispanic White women living in deprived neighborhoods face higher breast cancer mortality, highlighting the impact of social determinants on health outcomes.

Related Content

Wendie Berg, MD, PhD, discusses new breast density guidelines

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

Reducing geriatric breast cancer screening through cessation messaging

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.

Alzheimer disease risk reduced by hormone therapy for breast cancer treatment

In a recent study, older women receiving messages about breast cancer screening cessation were more likely to support stopping screening than those who did not receive a message.

Integrating HCV screening with breast cancer programs enhances care

A recent study found that hormone therapy use in breast cancer patients aged 65 years and older is associated with a reduced risk of Alzheimer's and related dementias.

Abigail Brooks, MA

Neighborhood deprivation linked to higher breast cancer mortality in White women